Item 7.01 Regulation FD Disclosure

On February 2, 2009, West Pharmaceutical Services, Inc. (the "Company") issued a press release announcing that Donald E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, and William J. Federici, Chief Financial Officer, will make a presentation at the UBS 2009 Global Healthcare Services Conference at the Waldorf Astoria in New York City on Tuesday, February 10, 2009 at 12:30 p.m. Eastern Time.

A copy of the Company's presentation from the conference will be available for 30 days through the Investor link at the Company's website, http://www.westpharma.com., and is also attached hereto as Exhibit 99.1. A copy of the press release is attached hereto as Exhibit 99.2. Both Exhibits are incorporated herein by reference.

The information in this report (including Exhibit 99.1 and 99.2) is being furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits Exhibit # Description 99.1 West Pharmaceutical Services, Inc. Corporate Overview (Investor Presentation). 99.2 West Pharmaceutical Services, Inc. Press Release, dated February 2, 2009.

---